A Study Evaluating Intravenous and Subcutaneous Administration of a Human Monoclonal Antibody (CNTO 5825) in Healthy Volunteers

10 mg/kg single dose IV or matching placebo

3 mg/kg single dose IV or matching placebo

For atopic patient:10 mg/kg single IV dose or matching placebo

For atopic patient: 3 mg/kg single dose SC or matching placebo

0.3 mg/kg single dose IV or matching placebo

0.1 mg/kg single dose Intravenously (IV) or matching placebo

1 mg/kg single dose IV or matching placebo